Home > Financial Ratios > AARTI DRUGS

AARTI DRUGS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results

AARTI DRUGS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 4.24-9.38-22.7066.6325.16

What is the latest Core EBITDA Growth ratio of AARTI DRUGS ?

The latest Core EBITDA Growth ratio of AARTI DRUGS is 4.24 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar20244.24
Mar2023-9.38
Mar2022-22.70
Mar202166.63
Mar202025.16

How is Core EBITDA Growth of AARTI DRUGS Trending?

Years Core EBITDA Growth % Change
Mar2024 4.24
Positive
Mar2023 -9.38
Negative
Mar2022 -22.7
Negative
Mar2021 66.63
164.83
Mar2020 25.16 -

Other Financial Ratios of AARTI DRUGS


Compare Core EBITDA Growth ratio of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹4,286.5 Cr -2.8% -12.9% -20.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,466.0 Cr -3% -6.8% -11.3% Stock Analytics
DIVIS LABORATORIES ₹162,423.0 Cr -0.5% -8.4% 25.1% Stock Analytics
CIPLA ₹128,405.0 Cr -0.2% 1% -1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,448.0 Cr -3.4% -5.6% 6.3% Stock Analytics
DR REDDYS LABORATORIES ₹105,408.0 Cr -1.1% -2.9% -9.5% Stock Analytics


AARTI DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

-2.8%

-12.9%

-20.8%

SENSEX

-2.7%

-1.3%

-2.3%


You may also like the below Video Courses